ProCE Banner Activity

Expert Guidance on Screening and Diagnosing Early AD

Clinical Thought

A huge component of improving the outlook for patients with mild cognitive impairment or Alzheimer’s disease is early identification. Learn what tools are available to assist in detecting and confirming signs of dementia or cognitive dysfunction and understand the ever-evolving treatment landscape of Alzheimer’s disease.

Released: September 19, 2023

Share

Faculty

Susan Scanland

Susan Scanland, MSN, CRNP, GNP-BC, CDP

National Dementia Expert
CEO and Founder, Dementia Connections LLC
Clarks Summit, Pennsylvania 

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Eisai.

Eisai

Disclosure

Primary Author

Susan Scanland, MSN, CRNP, GNP-BC, CDP

National Dementia Expert
CEO and Founder, Dementia Connections LLC
Clarks Summit, Pennsylvania 

Susan Scanland, MSN, CRNP, GNP-BC, CDP: consultant/advisor/speaker: Acadia Pharmaceuticals, BioXcel, Eisai, Otsuka/Lundbeck, Teva Pharmaceuticals.